Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE3188.75126.1 (+4.12 %)
PREV CLOSE () 3062.65
OPEN PRICE () 3110.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5364
TODAY'S LOW / HIGH ()3071.30 3200.00
52 WK LOW / HIGH ()2335 3314.8
NSE3189.70124.5 (+4.06 %)
PREV CLOSE() 3065.20
OPEN PRICE () 3095.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3189.70 (1)
VOLUME 140206
TODAY'S LOW / HIGH() 3071.20 3201.90
52 WK LOW / HIGH ()2329.9 3314.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office :

Address : Ajanta Tower, 54 - A,M V Road, Chakala,Andheri (East),
Mumbai,
Maharashtra-400093

Phone : 022-60609000 / 66061000

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
18Jun Ajanta Pharma informs about annual re
Ajanta Pharma has informed that the Forty-Seventh Annual General Meeting..
17Jun Ajanta Pharma informs about press rele
Ajanta Pharma has informed that it enclosed notice published in newspape..
15Jun Ajanta Pharma informs about AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
10Jun Ajanta Pharma’s promoter sells stake w
Ajanta Pharma’s promoter entity -- Ravi Agrawal Trust has sold 34.50 lak..
10Jun Ajanta Pharma trades higher on the bou
Ajanta Pharma is currently trading at Rs. 3075.00, up by 62.85 points or..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit1972.89468.2
Gross Profit 2576.1 12310.3
Operating Profit 3010.314023.9
Net Sales 12105.348459.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma (BSE)
 8556.55 (1.78%)
M.Cap ( in Cr)
21391.38
Mankind Pharma (BSE)
 2537.05 (4.95%)
M.Cap ( in Cr)
104779.14
NGL Fine-Chem (BSE)
 3156.15 (2.67%)
M.Cap ( in Cr)
1949.88
Coral Laboratories (BSE)
 621.50 (13.11%)
M.Cap ( in Cr)
222.04
Cipla (BSE)
 1415.30 (4.54%)
M.Cap ( in Cr)
114334.35
Shareholding Pattern
PROMOTERS 66.25%
MUTUAL FUNDS/UTI 15.22%
NON-INSTITUTION 7.12%
FI/BANKS/INSURANCE 2.7%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77094.07291.17 (0.38%)
NIFTY24102.9089.80 (0.37%)
Dow Jones 51564.7072.15 (0.14%)
Nasdaq 26517.93496.27 (1.91%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI